We need more empirical studies about the impact of generative AI on our mental health. I dissect one recent study to show counterintuitive results. An AI Insider scoop.
Recent research published in the Journal of Psychopharmacology suggests that the use of psychedelic substances does not ...
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic ...
With the market for GLP-1 weight-loss drugs increasing rapidly, consumer apps that send reminders, track progress, and explain side effects, are emerging. While there are no data on the number of ...
An independent, research-informed evaluation of the Bioma probiotic formulation - examining its ingredients, dosage ...
We hope you've had a chance to review the press release we issued after market close in the U.S. today, announcing the positive top-line results of the Phase III ABTECT Maintenance trial. Joining me ...
Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries from severe long Covid, achieved entirely outside mainstream medicine. The ...
Play By Play Studios CEO Scott Probst explains what will make ‘NBA The Run’ unique when it launches June 9. Jon Hartzell, NBA ...
Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...
The combination of pharmacotherapy and psychotherapy is associated with reductions in emergency department visits and inpatient admissions along with lower total cost of care relative to either ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) ('MAIA”, the 'Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, delivered a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results